Drug Trial Radar · NCT00768599
A Study of Econazole Foam 1% in Athlete's Foot
Last checked: Nov 19, 2026Latest source record: Jan 9, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
135
Actual
Start
Mar 2008
Primary completion
Sep 2008
Study completion Oct 2008
Sponsor
- Lead sponsor
- AmDermaIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescribe to treat athlete's foot. This study will help to understand if the foam works the same as the cream to treat athlete's foot.
Conditions
- Tinea Pedis
- Athlete's Foot
Interventions
Econazole Nitrate Cream 1%Drug
Topical cream, applied once daily for 4 weeks.
Econazole Nitrate Foam 1%Drug
Topical foam, applied once daily for 4 weeks.
Vehicle FoamDrug
Topical foam, applied once daily for 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Cure Rate: Interdigital DiseaseTime frame: Day 43
- Complete Cure Rate: Moccasin DiseaseTime frame: 43 Days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Stacy Smith, MD
San Diego, California
Daniel Stewart, DO
Clinton Township, Michigan
Steven Kempers, MD
Fridley, Minnesota
Michael Gold, MD
Nashville, Tennessee
Michael Jarratt, MD
Austin, Texas
Leonard Swinyer, MD
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.